Addressing Peri-Device Leaks in Next-Generation Transcatheter Left Atrial Appendage Occluders: An Open Question
Open Access
Abstract
With FDA-approved devices, left atrial appendage (LAA) occlusion has emerged as a well-established and rapidly growing approach to stroke prevention in patients with non-valvular atrial fibrillation. These devices are indicated for use in patients who are at increased risk of stroke and systemic embolism, as determined by CHA2DS2-VASc scores, and are suitable for anticoagulation therapy, with an appropriate rationale for seeking a non-pharmacologic alternative. This includes patients who may be unsuitable for long-term anticoagulation due to contra-indications. These devices, generally consisting of a nitinol-framed structure with a circular cross-section, are positioned within the LAA to obstruct the ostium, effectively preventing the thrombus from embolizing the brain. The initial clinical data from pivotal trials and observational registries indicated no strong correlation between peri-device leaks (PDLs) and adverse events. However, recent studies have shown that PDLs are associated with a higher risk of thrombo-embolic events, leading to renewed interest in managing PDLs. This paper reviews the occurrence of PDLs after percutaneous LAA occlusion using current FDA-approved devices, highlighting the need for non-circular occluders to better-accommodate the inherent variability in LAA anatomy. It also compares the benefits and limitations of emerging approaches still under investigation, focusing on addressing PDLs.Keywords
Funding Information
- Dalio Institute of Cardiovascular Imaging (T32HL098069)
- Yale T32 (T32HL098069)
This publication has 102 references indexed in Scilit:
- Understanding the role of the left atrial appendage on the flow in the atriumCatheterization and Cardiovascular Interventions, 2024
- Upconversion 3D Bioprinting for Noninvasive In Vivo MoldingAdvanced Materials, 2024
- Risk factors, clinical implications, and management of peridevice leak following left atrial appendage closure: A systematic reviewJournal of Interventional Cardiac Electrophysiology, 2024
- Left atrial appendage sealing performance of the Amplatzer Amulet and Watchman FLX deviceJournal of Interventional Cardiac Electrophysiology, 2022
- Left atrial appendage closure with the II generation Ultraseal device: An international registry. The LIGATE studyCatheterization and Cardiovascular Interventions, 2022
- Temporal changes and clinical significance of peridevice leak following left atrial appendage occlusion with Amplatzer devicesCatheterization and Cardiovascular Interventions, 2022
- Leak closure following left atrial appendage exclusion procedures: A multicenter registryCatheterization and Cardiovascular Interventions, 2022
- Incidence, predictors and outcomes of device‐related thrombus after left atrial appendage closure with the WATCHMAN device—Insights from the EWOLUTION real world registryCatheterization and Cardiovascular Interventions, 2021
- Advanced Manufacturing of Patient‐Specific Occluders for the Left Atrial Appendage with Minimally Invasive DeliveryAdvanced Engineering Materials, 2020
- Stereolithography for Personalized Left Atrial Appendage OccludersAdvanced Materials Technologies, 2018